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115Principal considerations for the contemporary
high-ﬁdelity endovascular simulator design used
in training and evaluation
Benjamin A. Eslahpazir, MS,a Jerry Goldstone, MD,b Matthew T. Allemang, MD,b John C. Wang, MD,b
and Vikram S. Kashyap, MD,b Orlando, Fla; and Cleveland, Ohio
Background: The simulation and rehearsal of virtual endovascular procedures are anticipated to improve the outcomes
of actual procedures. Contemporary, high-ﬁdelity simulation is based on feedback systems that combine concepts of
mechanical, electrical, computer, and control systems engineering to reproduce an interactive endovascular case. These
sophisticated devices also include psychometric instruments for objective surgical skill assessment. The goal of this report
is to identify the design characteristics of commercially available simulators for endovascular procedures and to provide a
cross-section comparison across all devices to aid in the simulator selection process.
Methods: Data were obtained (1) by a standard questionnaire issued to four simulator companies prompting for relevant
design details of each model for the expressed purpose of publication, (2) from each manufacturer’s respective website
including appended sales brochures and speciﬁcation sheets, and (3) by an evaluation of peer-reviewed literature. Focus
topics include haptic technology, vessel segmentation, physiologic feedback, performance feedback, and physical logistics
(ie, weight, dimensions, and portability). All data sources were surveyed between January 1, 2012, and June 30, 2013.
Results: All of the commercially available, high-ﬁdelity endovascular simulators use interactive virtual environments with
preprogrammed physics and physiology models for accurate reproduction of surgical reality. The principal differences
between devices are the number of access sites and haptic devices, the ability to reconstruct patient-speciﬁc anatomy for
preprocedural rehearsal, and the available peripheral training modalities. Hardware and software options can also vary
within the same device in comparing patient-speciﬁc with generic cases.
Conclusions:Despite our limited knowledge about the potential of high-ﬁdelity simulation within the endovascular world,
today’s currently available simulators successfully provide high-ﬁdelity reproductions of the endovascular environment.
We have found that all of the commercially available devices incorporate the necessary features for a high-ﬁdelity
experience: (1) haptic technology, (2) vessel reconstruction, (3) physiology feedback, and (4) performance feedback.
Signiﬁcant variations in design do exist and may inﬂuence differences in skill development, evaluation, or cost. However,
further validation of these differences is still needed and would beneﬁt program directors interested in expanding these
platforms for vascular training and certiﬁcation as this technology matures. (J Vasc Surg 2014;59:1154-62.)The endovascular management of cardiovascular dis-
ease has progressed dramatically. Diagnostic angiography
limited to the peripheral and cerebral vasculature has
evolved to complex endovascular procedures in nearly all
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4and devices. The traditional training paradigm of teaching
procedures while performing them on patients who are
often critically ill is challenging in the face of increasing
case complexity and an environment of duty-hour restric-
tions. Simulation and rehearsal of endovascular procedures
may improve outcomes by accelerating the learning curve
for both trainees and experienced physicians performing
new procedures. There is also, perhaps more than ever,
an added need to deﬁne the necessary training require-
ments for competency as new devices and procedures arise.
The ability to improve skills, to gain technical experi-
ence, and to validate competency without placing a patient
at risk has always been a challenge for educators as well as
for trainees and has led to widespread adoption of cadaver
and animal models, albeit at high costs.1,2 The advent of
high-ﬁdelity virtual reality surgical simulators opened a
new avenue of procedural training and examination, raising
questions about the apprenticeship model or traditional
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nology. One of the ﬁrst computerized surgical simulators
was described by Satava in 1993 for laparoscopic surgery
with a three-dimensional reconstruction of the human
abdomen.3 Laparoscopic simulation paved the way for
other surgical specialties when virtual technology was
adapted for skills training. Since then, the role of virtual
reality simulators has expanded into other surgical
subspecialties.
In 2004, Gaba described the 11 dimensions of medi-
cal simulation that are directly applicable to the endovas-
cular world.4 Virtual reality simulators are now a
platform for endovascular skills development, standard-
ized certiﬁcation, and patient-speciﬁc procedure rehearsal.
Multiple commercially available virtual reality simulators
are marketed today in the United States speciﬁcally designed
for endovascular procedures. Each device offers unique
characteristics, different technologies, and different logistical
features. This makes simulator selection a complex process
for obvious reasons. However, a large question remains as
to which simulation features provide the greatest beneﬁts
for different end goals, such as training, rehearsal, and
certiﬁcation.
The four predominant virtual reality endovascular
simulation manufacturers today are Mentice AB, Simbionix
Corporation, Medical Simulation Corporation, and CAE
Healthcare. Among the four manufacturers, seven models
are available for purchase, including the VIST-Lab and
VIST-C from Mentice; the SimSuite Simantha from Med-
ical Simulation Corporation; the ANGIOMentor Slim,
Dual Slim, and Ultimate from Simbionix; and the CathLab
VR from CAE Healthcare (Fig 1). This report serves
to identify the design characteristics of this commercially
available product line, aiding in the simulator selection
process and providing a basic understanding of this high-
ﬁdelity technology. We focused on the major areas of
haptics, vessel segmentation, physiologic feedback, and
performance feedback throughout this document. To assist
vascular surgery program directors, other educators, and
clinicians in selecting an appropriate simulator, we have
collected and compared the available physical speciﬁcations
(Table I) and technical information (Table II) about these
devices.
METHODOLOGY
The manufacturers were requested to provide informa-
tion about their devices with use of a standardized survey
instrument provided to corporate representatives. Dis-
claimers were included to inform each representative of
our intent to publish and to acknowledge that all responses
should be voluntarily provided at their discretion. Addi-
tional information was obtained from online marketing
materials appended to each manufacturer’s website,
including sales brochures and speciﬁcation sheets. Peer-
reviewed literature served as the third data source. All sour-
ces were surveyed between January 1, 2012, and June
30, 2013.HAPTIC TECHNOLOGY
Haptic feedback, deﬁned as the intelligent generation
of sensory or tactile information by an electromechanical
system in response to user-guided inputs, is inseparable
from endovascular simulator training. It is responsible for
applying the appropriate forces on a cannulating device
to recreate the force feedback essential for image-assisted
navigation. Force feedback is thought to be essential for
development of tactile dexterity while providing added in-
formation about device orientation within a ﬂuoroscopi-
cally projected vascular environment. Haptic devices
recreate both contact and frictional forces characteristic
of catheter-intima collisions and allow the user to form
an intuitive correlation between tactile cues and device
guidance.
Input parameters for any cannulating device are limited
to two degrees of freedom because of constraints enforced
by the typical introducer or sheath. These degrees of
freedom are (1) bidirectional translation along the longitu-
dinal axis (6Dz) and (2) bidirectional rotation about the
longitudinal axis (6r) of the access device. More than
one cannulating device can be simultaneously employed
within a simulator and independently provide its own de-
grees of freedom (Fig 2, A). This permits manipulation
of one device while the other may either remain stationary
or undergo a separate mode of motion. Some endovascular
devices include three haptic units per access such that a
guidewire, catheter, and sheath can be independently
controlled by their own dedicated haptic device.
Ilic et al5 reported that the normal range of forces encoun-
tered during catheterization falls between 61.3 newtons for
translation and 64.5 millinewton-meters for rotation
measured by a Fabry-Perot strain gauge within a polyvinyl
alcohol model fashioned into a human arterial network. The
resolution of human sensitivity to vibration has been
measured to be 1mmat 300Hz6 and is a design consideration
in haptic refresh rates to ensure a smooth tactile response.
When it is inserted into the haptic unit, the cannulating
device’s position is tracked and processed by optical encoders
with spatial resolutions reported up to 0.004 mm for transla-
tion and 0.5 degree for rotation.7 These sensors encode input
information into a digital format and are a principal require-
ment for delivery of spatial information from physical reality
to virtual reality. The virtual reality is governed by theoretical
laws of physics to accurately transform the input data into
predictive output data based on the physical constraints of
the virtual vascular geometry and mechanical properties of
the interventional device. Output commands generated by
the computational physics model control onboard motors
within each carriage to provide accurate force feedback. Vir-
tual reactive forces to collision andwall friction are reproduced
by actuators in the haptic unit that compress together inoppo-
sition around the inserted device andmay drive the device by a
DCmotor if it is an active haptic device or just restrict freedom
of movement if it is a passive haptic device.
Active haptics is a force feedback system that can add
energy into a system (ie, DC motoredriven active
Fig 1. Commercially available endovascular simulators: VIST-Lab and VIST-C (reproduced with permission of
Mentice AB); ANGIOMentor Ultimate and ANGIOMentor Slim (reproduced with permission of Simbionix USA
Corporation); SimSuite Simantha (reproduced with permission of Medical Simulation Company); and CathLab VR
(reproduced with permission of CAE Healthcare).
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Passive haptics is a design that can only remove energy
from a system by way of damping the movement of an ob-
ject in motion. This is achieved by compression around
the cannulating device as it passes through the haptic sys-
tem. Because passive haptics does not require high rota-
tional force outputs, the passive system avoids control
issues inherent in high-inertia systems and permits
improved control ﬁdelity and consequential improvement
in time resolution.8 Today’s most comprehensive simu-
lator designs consolidate active and passive properties
into a single system and permit both the generation and
inhibition of complex forces often encountered within
the tactile experience. The simultaneous use of active
and passive haptics is not universal across all software
suites, and active haptics often remain dormant during
patient-speciﬁc rehearsals.
All of the simulators include collision detection (the
ability for the physics model to detect a simulated collision
between the modeled catheter and the virtual vascular
wall). Collision detection is required to compute theoret-
ical contact forces generated from the collision event to
update the haptics output with refreshed calculations(Fig 3) similarly described by Dawson et al9 in their devel-
opment of a simulator for interventional cardiology
training.
VESSEL SEGMENTATION
Vessel segmentation is the process of isolating vascular
lumen data from all other tissues contained within a
computed tomographic angiography (CTA) or magnetic
resonance angiography (MRA) data set and is required
for creating a three-dimensional interactive vascular envi-
ronment. For generic patient cases, vessel segmentation is
completed and provided by the manufacturer before pur-
chase of the virtual ﬁle. For patient-speciﬁc cases, manual,
semiautomatic, or fully autonomous segmentation tech-
niques can be employed to convert raw CTA or MRA im-
ages from the two-dimensional data set.
Automatic segmentation capabilities are included in
some software packages and mostly depend on a precali-
brated contrast intensity standard applied by radiologists
to most contrast-enhanced CTA and MRA images. This
standard is required to ensure the normal processing of
established autosegmentation techniques.10-12 Most
patient-speciﬁc segmentation techniques require prior
Table I. Physical speciﬁcations for commercial endovascular simulators
Manufacturer Mentice
Medical
Simulation
Corporation Simbionix
CAE
Healthcare
Model VIST-Lab VIST-C Simantha
ANGIOMentor
Slim
ANGIOMentor
Dual Slim
ANGIOMentor
Ultimate
CathLab
VR
Dimensions 257  81  196 cm
(mannequin
height is 116 cm
and adjustable)
117  41  15 cm
for device;
required total
tabletop space:
152  61 cm
183  183 
76 cm
104  10  13 cm 104  10  13 cm
for each device
(2)
127  61  168 cm d
Weight d 13.15 kg for device,
5 kg for laptop
and monitor
222.25 kg
for system
4 kg for device, 4 kg
for laptop, and
3.2 kg for
monitor
8.2 kg for 2 devices,
4 kg for laptop,
3.2 kg for
monitor
150 kg for system d
Portability On casters, portable
within building
Can be checked in
on airplane
On casters,
portable within
building
Can be checked
in on airplane
Can be checked
in on airplane
On casters, portable
within building
d
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turer, depending on the terms of purchase. However, ef-
forts are being made to streamline the segmentation
process with the end goal of timely completion
(w15 minutes) by a formally trained clinician, thereby
minimizing opportunity costs. Most case-speciﬁc segmen-
tations involve isolation of relevant vascular structures
speciﬁc to the corresponding procedure. This requires
removal of all other tissues by way of establishing reason-
able Hounsﬁeld unit thresholds within the software settings
and isolating hyperdense structures (contrast-enhanced
lumen, ossiﬁed or calciﬁed tissues, metallic stents) in addi-
tion to establishing relevant axial slice boundaries (ie,
thoracic, abdominal, pelvic, lower extremity). Numerous
computational methods exist for vessel segmentation, and
at least eight major methods of vessel segmentation can
be used for simulation.13 The algorithm type employed
by each simulator model has not yet been elucidated.
The endoluminal space is the volume of interest for
most interventional applications. However, extraluminal
information, such as vessel wall thickness, thrombus struc-
tures, or calciﬁc plaques, may be relevant to procedure
rehearsal or device selection. Identiﬁcation of focal or
diffuse calciﬁcations before modeling can be accomplished
when true lumen is differentiated from encroaching cal-
cium by tracking and differentiation of hyperintense cal-
cium from noncalciﬁed contrast-enhanced lumen. This is
indeed possible by specifying high-end boundary thresh-
olds when deﬁning contrast intensity11 and is a strategy
often used in both the manual segmentation and autoseg-
mentation processes.
PHYSIOLOGIC FEEDBACK
Physiologic feedback is incorporated into all of these
systems to recreate a theoretical response (either normal
or aberrant) to pharmacologic or mechanical interventions.
These interventions can result in a variety of changes spe-
ciﬁc to the input and may be displayed and modiﬁed in
real time or recorded within a postoperative report. Insome systems, basic metabolic panel data can be recalled
on demand by the interventionist during generic cases.
Pharmacologic interventions can be delivered through a
number of routes and administration ratesdcontinuous
intravenous drip infusion, periodic intravenous bolus,
intra-arterial or coronary infusion by ﬂuoroscopically
directed catheterization, or directed delivery through
drug-eluting intra-arterial or coronary angioplasty. Most
of these interventions generate a feedback output through
use of a predictive physiology model. Nonpharmacologic,
mechanical events between the virtual interventional device
and the reconstructed endovascular environment can
generate performance feedback in the form of perioperative
complications or pathophysiologic change. This technol-
ogy has yet to translate to patient-speciﬁc platforms and
is mostly limited to generic training modules.
PERFORMANCE FEEDBACK
The expanding role of simulation for surgical training
has led to the development of instructional feedback tools
as a standard feature. Although performance metrics may
differ between manufacturers and also between generic
and patient-speciﬁc applications, they are a common feature
in the simulation experience.Metrics can be presented either
in real time during the measured event or as an itemized
postprocedural report. Regardless, the detail and content
of these reports vary between models and between generic
and patient-speciﬁc cases. Thus, performance feedback
should be thoroughly considered during product selection.
Overall, we have conﬁrmed that each manufacturer
provides performance feedback. These metrics can be
used for procedural training, skill validation, or complex
procedure rehearsal. Performance feedback is essential for
ensuring a practice directed with intent. However, simula-
tion develops a limited set of surgical skills and has yet to
address other aspects of operative performance, such as
cognitive development of anatomic recognition, tactful
judgment, and preparation for alternative scenarios,14 and
it should thus be valued accordingly.
Table II. Technical speciﬁcations of current endovascular simulators
Simulator
Manufacturer Mentice
Medical
Simulation
Corporation Simbionix
CAE
Healthcare
Simulator model VIST-Lab VIST-C Simantha
ANGIO
Mentor
Slim
ANGIO
Mentor
Dual Slim
ANGIO
Mentor
Ultimate CathLab VR
Number of
haptic units
6a 3 6 3 6 6 d
Active or passive
haptics
d d Both Both Both Both d
Haptics company
or model
Xitact CHP15 Xitact CHP15 Proprietary Xitact CHP15 Xitact CHP15 Xitact CHP15 Proprietary15
DOF 2 2 d 2 2 2 d
DFF 2 2 d 2 2 2 d
Maximum force d d d Station A: 15N
Station B: 8N
Station C: 8N
Station A: 15N
Station B: 8N
Station C: 8N
Station A: 15N
Station B: 8N
Station C: 8N
d
Collision detection Yes Yes Yes Yes Yes Yes d
Fluid dynamics d d Yes Yes Yes Yes d
Patient-speciﬁc
capabilities
Yes Yes No Yes Yes Yes d
Peripheral
modalities
Carotid, renal,
iliac/SFA,
vena cava,
below-
the-knee
Carotid, renal,
iliac/SFA,
vena cava,
below-
the-knee
Carotid, iliac,
renal, SFA
Carotid, renal,
iliac, SFA,
EVAR,
TEVAR,
below-
the-knee,
pulmonary
Carotid, renal,
iliac, SFA,
EVAR,
TEVAR,
below-
the-knee,
pulmonary
Carotid, renal,
iliac, SFA,
EVAR,
TEVAR,
below-
the-knee,
pulmonary
Carotid, 5 basic
cases with type I
and II arches
and 5 advanced
cases with
type III and
IV (bovine)
arches
PACS
compatible
d d No Yes Yes Yes d
DOF, Degrees of freedom; DFF, degrees of force feedback; EVAR, endovascular abdominal aortic aneurysm repair; PACS, picture archiving and commu-
nication system; SFA, superﬁcial femoral artery; TEVAR, thoracic endovascular aortic repair.
aBased on images found at http://www.mentice.com/our-simulators/vist-lab.
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The Simbionix design includes three independent haptic
devices per access site such that their portable ANGIOMen-
tor Slim models contain three haptic devices, similar to the
equivalent Mentice linear module depicted in Fig 4, A.
The full-size Simbionix ANGIOMentor Ultimate includes
two access sites and therefore contains six independent
haptic devices, also analogous to the Mentice counterpart
shown in Fig 4, B. The Fmax generated at each of the three
active haptic stations within a Simbionix linear module was
reported to be at least 8N, well above the 1.3N reported
by Ilic et al.5 This maximum force value is the peak force
capable of being generated by each haptic unit. The Simbio-
nix devices require conversion of raw CTA andMRA images
to the DICOM standard before patient-speciﬁc cases can be
employed and likely require collaboration with a radiologist.
Nonetheless, the Simbionix vessel segmentation procedure
is semiautomatic and can be completed by a trained clini-
cian, even during the day of surgery. Anatomic complexity
correlates with segmentation time and may consume 30 to
60 minutes of preoperative preparation for more complex
cases. Also, semiautomatic and manual segmentation is
inherently subject to interuser variance, a factor thus far
overlooked throughout the literature.Physiologic feedback is another prominent feature of
the Simbionix software. Quantitative vital signs include
heart rate, invasive blood pressure (ie, aortic pressure)
measured through catheters, intracardiac pressures
measured by transseptal needles, oxygen saturation levels,
cuff blood pressures, and catheter-directed intra-arterial
pressures. Waveform vital signs include various electrocar-
diographic lead signals, aortic blood pressure, intracardiac
pressure, and electrophysiology electrograms. Other pa-
rameters tracked and reported by the Simbionix device
include the lowest and highest sustained heart rate and
blood pressure during the procedure, the patient’s heart
rate and systolic blood pressure at the end of the case,
and the activated clotting time levels both at the beginning
of the procedure and during device deployment. Drug op-
tions for the Simbionix devices include anticoagulants,
antiplatelets, chronotropes, antiarrhythmics, beta-blockers,
vasodilators, antihypertensives, vasopressors, and procoa-
gulants. Drug administration may affect the patient’s vital
signs, electrocardiographic readings, and coagulation
time. The ANGIOMentor system is also capable of gener-
ating the following complications: vessel dissections, perfo-
rations, vasospasms, aortic puncture or leak, and air
embolizations, all in real time during the procedure.
Fig 3. Information exchange between physical and virtual reality.
Force input from the surgeon drives physical catheter, guidewire, or
sheath through the haptic device (a). Encoder-deﬁned digital inputs
from haptic device are delivered to the virtual physics model to
compute a reactive collision force (b). Virtual collision force com-
mand is dispatched back to the haptic device (c). Passive or active
haptic drive generates forces applied to the physical device for
reconstructing the theoretical tactile response (d). Fi, Input force;
Fv, virtual collision force; Sf, feedback signal; Fo, output force.
Fig 2. Representative concepts of device-simulator interaction. A, Schematic of guidewire and catheter guide assembly
typical for endovascular haptic devices. Independent guides for each interventional device, when used simultaneously
within a single haptic module, permit independent manipulation of each device without inﬂuencing the other. Dzc,
Linear degree of freedom for catheter; Dzg, linear degree of freedom for guidewire; rc, rotational degree of freedom for
catheter; rg, rotational degree of freedom for guidewire. B, Generalized haptic-catheter interface. In active haptics, the
active cylinder can be shaft driven by a digitally controlled DC motor for input of added force.
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parameters are tracked during a procedure and reproduced
in the form of a postoperative report. These parameters
include total procedure time, total ﬂuoroscopy time, total
three-dimensional time (an artiﬁcial overlay on the ﬂuoro-
scopic screen used to assist with navigation), time to com-
plete deployment of all graft components if used, number
of roadmaps, number of interventional maneuvers, number
of devices used, drugs administered, procedural events,
changes in vital signs, imaging actions, and corresponding
times for each event. Simbionix simulators also have
device-speciﬁc features. For example, it can trackendovascular abdominal aortic aneurysm repairespeciﬁc er-
rors and metrics, including graft components not intro-
duced through an introducer, graft components not
introduced over a stiff wire, distance of advancing graft
components without a leading wire, correct diameters of
main body selected, correct positioning of main body
selected, occurrence of endoleak during intervention,
conﬁrmation of adequate endoleak exclusion, and inadver-
tent ostial masking (left/right hypogastrics, left/right re-
nals, or superior mesenteric artery) during an
endovascular aneurysm repair rehearsal. Again, these fea-
tures may differ between generic and patient-speciﬁc cases
and should be a consideration before purchase. Although it
is beyond our discussion, device-speciﬁc features are also
available for the other models featured in this document
and should be considered before selection.
MENTICE
In 2005, Mentice acquired Xitact, a company that
specialized in modular medical force feedback haptic hard-
ware. Coles et al15 stated that both Mentice and Simbionix
incorporated the Xitact CHP haptic device into their endo-
vascular product line. If both Mentice and Simbionix still
use the same haptics hardware, then the Mentice active
haptics can also generate an Fmax of at least 8N. Unfortu-
nately, we were not able to conﬁrm comparable Fmax
data for the other manufacturers. Both active and passive
haptics are available in the Mentice devices.
For patient-speciﬁc cases, CTA and MRA patient data
must be transferred to a Mentice-authorized technician
to generate a workable model. This process has been re-
ported to delay simulation for up to 1 week but does
have the advantage of outsourcing to an experienced tech-
nician when multitasking is important.16
Fig 4. Simulator assembly for Mentice devices. A, Single linear
module that includes three separate haptic carriages per module.
Each carriage independently operates its own haptic unit (cross-
hatched ﬁll). B, VIST-Lab containing two equivalent linear mod-
ules (crosshatched ﬁll) typically concealed within a protective
encasement.
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ity of 15 drug options, which include morphine, heparin,
and nitroglycerin for their devices. The physiology model
also provides real-time feedback for catheter-measured
aortic pressure, any 3-lead waveforms from a 12-lead elec-
trocardiographic system, cuff blood pressure, heart rate,
respiratory rate, and oxygen saturation. According to van
Herzeele et al,17 the Mentice product line monitors both
errors and clinical parameters including total procedure
time, total amount of contrast material used, number of
cine loops, and total ﬂuoroscopy time. Qualitative errors
include catheter-vessel errors (excessive pressure of a diag-
nostic or guiding catheter against the vessel wall), catheter
movement errors (advancing a diagnostic or guiding cath-
eter beyond the guidewire or advancing a guiding catheter
near the site of a lesion), migration of an embolic protec-
tion device either during or after deployment, prematurestent deployment, stent migration after deployment, and
premature balloon inﬂation within the guiding catheter
or sheath. Additional measures include tools used (diag-
nostic catheter, guiding catheter or sheath, embolic protec-
tion device with reported size and angle tip, predilation and
postdilation balloon size and length, stent size and length),
placement accuracy of predilation and postdilation balloon
and stent, percentage lesion covered by either a balloon or
stent, relevant balloon/vessel and stent/vessel contact ra-
tios, maximum pressure released during deployment of
either a balloon or stent, and residual stenosis after both
balloon predilation and postdilation of stent.
MEDICAL SIMULATION COMPANY
Medical Simulation Company uses a proprietary haptic
interface within its Simantha simulator15 that also follows
the 3:1 ratio of haptic units per access. Medical Simulation
Company also conﬁrmed that similar perioperative data are
tracked with their device, including intra-arterial blood pres-
sure, cuff blood pressure, oxygen saturation, and activated
clotting time. We have also found that the Simantha system
includes more than 20 drug classes, although the details of
each class remain unknown. The Simantha is capable of
generating perioperative complications including dissections,
perforations, arrhythmias (ventricular ﬁbrillation, ventricular
tachycardia, atrial ﬁbrillation, atrioventricular block, torsades
de pointes), vasospasm, no reﬂow, bradycardia, hyperten-
sion, contrast agent reactions, hypotension, vasovagal re-
ﬂexes, embolism, and oversedation. The Simantha can
generate multiple feedback data points during percutaneous
coronary interventions, such as number of stents used,
guidewire selection, stent placement characteristics (length,
diameter, target vessel identiﬁcation, and segment region),
injected volume of contrast material, ﬂuoroscopy time,
balloon characteristics (length, diameter, and type), drug
administration characteristics (drug type, volume, and
route), number and type of adverse events, and time to
completion18; other studies have indicated similar metrics
for peripheral cases, speciﬁcally renal and carotid stenting.19
However, we were not able to conﬁrm if these metrics were
included in all peripheral modalities. Information provided
by Medical Simulation Company stated that qualitative
and quantitative data are recorded during each simulation
case and are based on speciﬁc training objectives, resulting
in a postprocedural summary report.
CAE HEALTHCARE
Even after our investigation, the mechanical and con-
trol parameters of the CAE Healthcare device still remain
unknown. Nonetheless, we do know that the CathLab
VR uses its own proprietary haptic interface15 and that it
does generate its own real-time metrics, which include a
cumulative procedure time, ﬂuoroscopy time, cine loop
time, running total of infused contrast material, and cath-
eter tip pressures. In addition, postoperative reports
include types of complications, total number of still images
saved, and total radiation exposure; record logs itemize
contrast agent injection, stent characteristics (residual
JOURNAL OF VASCULAR SURGERY
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deployment, and overall procedure details. For this device
and all others included in this report, we did not attempt
to correlate performance feedback characteristics to perfor-
mance outcomes. Accordingly, these characteristics still
remain unvalidated and persist as an unmet need in the
endovascular simulation literature.
CONCLUSIONS
The morbidity and mortality of complex interven-
tional cardiovascular and peripheral vascular procedures
combined with the current emphasis on patient safety
have played an important role in the adoption of simula-
tors. Simulation of patient events and resuscitation man-
nequins have been used for training and certiﬁcation for
years.20,21 With the recent introduction of high-ﬁdelity
virtual reality simulators, there is a great potential to
reduce experience-dependent risks for both trainees and
expert physicians performing new procedures in clinical
practice.22 A substantial effort has been put forth to deﬁne
the role of endovascular simulation training for interven-
tions in vascular beds other than the coronaries, and it
has proved to be useful for carotid artery stenting23,24
and endovascular aneurysm repair.25 However, there is
still a need to evaluate the educational value of high-
ﬁdelity endovascular systems based on actual outcomes
rather than on expert testimony.
Face validity is deﬁned as “validity that is assessed by
having experts review the contents of the test or the testing
instrument to determine if it seems appropriate to the task
being tested”26 but should be treated as an accessory to
evidence-based outcomes. For example, despite the low
resemblance to the external human form, experimental ev-
idence for current simulator designs concludes that they
remain effective training tools.14,27-29 It is thus important
to note that face validity is loosely associated with training
potential. Accordingly, a simulator’s criteria for quality
must extend beyond face validity, and increasing compe-
tency should precede recreating the experience. David
Gaba was correct in that simulation is “a technique rather
than a technology,” but the primary end point should
not be limited to recreating an experience. According to
Gallagher et al,30 the use of simulation for surgical training
must extend beyond face validation and address more
important questions, such as does it develop the correct
skills, does it work well, and what is the quality of evidence?
Thus, the end goal should be improvement or validation of
surgical skill. Unfortunately, there is a current lack of
consensus regarding which metrics lead to improved clin-
ical outcomes. As validation studies mature into prospec-
tive comparisons between training and outcomes, we can
then intelligently select or improve simulator designs for
targeted purposes (ie, advancing the novice through tradi-
tional performance benchmarks, reducing procedural time,
or teaching a novel technique).
Both the American College of Cardiology and the
Association of Program Directors in Vascular Surgery
have endorsed the use of simulators for procedural skilltraining. In addition, in 2004 the Food and Drug Admin-
istration approved the use of simulator training for certiﬁ-
cation in carotid stent placement in a ﬁve-step system. All
of the virtual reality simulators proﬁled in this review incor-
porate the important features necessary to successfully
accomplish the objectives of their use, but different design
features may produce differences in skill development
or validation. Understanding of the variations between
each model is advantageous to those responsible for pur-
chasing a simulator and the implementation of endovascu-
lar training and certiﬁcation programs.AUTHOR CONTRIBUTIONS
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